In December 2019 in Wuhan (China), a bat-origin coronavirus (2019-nCoV), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified, and the World Health Organization named the related disease COVID-19. Its most severe manifestations are pneumonia, systemic and pulmonary thromboembolism, acute respiratory distress syndrome (ARDS), and respiratory failure. A swab test is considered the gold standard for the diagnosis of COVID-19 despite the high number of false negatives. Radiologists play a crucial role in the rapid identification and early diagnosis of pulmonary involvement. Lung ultrasound (LUS) and computed tomography (CT) have a high sensitivity in detecting pulmonary interstitial involvement. LUS is a low-cost and radiation-free method, which allows a bedside approach and needs disinfection of only a small contact area, so it could be particularly useful during triage and in intensive care units (ICUs). High-resolution computed tomography (HRCT) is particularly useful in evaluating disease progression or resolution, being able to identify even the smallest changes.
【저자키워드】 COVID-19, SARS-CoV-2, Pneumonia, CT, Ultrasound, US, 【초록키워드】 ARDS, coronavirus, Respiratory failure, acute respiratory distress syndrome, Pneumonia, 2019-nCoV, Triage, intensive care unit, severe acute respiratory syndrome Coronavirus, China, Computed tomography, Disease progression, early diagnosis, sensitivity, intensive care units, HRCT, false negatives, Wuhan, Thromboembolism, Disinfection, gold, Swab test, respiratory, disease, acute respiratory distress, Pulmonary thromboembolism, Contact, manifestation, respiratory distress, Health Organization, related disease, World Health Organization, changes, Radiologists, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, gold standard, syndrome, pulmonary involvement, ICUs, radiologist, approach, interstitial, identify, diagnosis of COVID-19, 【제목키워드】 literature review,